World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

EVALUATION OF THE ANTI-DIABETIC AND BIOCHEMICAL EFFECTS OF PHYTOCHEMICALLY CHARACTERIZED ETHANOL SEED EXTRACT OF PERSEA AMERICANA (AVOCADO) ON ALLOXAN INDUCED DIABETIC RATS

Nwankpa Promise, Nwabueze Obinna Stephen and Uche Mercylyn Ezinne*

ABSTRACT

Persea americana has been used in folklore medicine for the management of obesity, hypertension and diabetes mellitus. This research investigated the antidiabetic and biochemical effects of phytochemical characterized ethanol seed extract of Persea americana (ESEPA). The phytochemical characterization of seed extract of P. amaricana (SEPA) was carried out using Gas Chromatography Mass Spectrometry (GC-MS). In the acute toxicity study, animals were given oral doses of ESEPA ranging from 0.5g/kg to 5g/kg. Diabetes was inducted using a single intraperitoneal injection of 150mg/kg of alloxan. For the subacute toxicity test which lasted for 14 days, rats were divided into six (6) groups of five animals each. Group 1 was normal control, group 2 negative control, group 3 positive control, groups 4,5 and 6 were given 200mg/kg, 400mg/kg and 600mg/kg respectively. Group 2-6 rats were all induced with diabetes. Standard analytical protocols were follwed during the experiment. GC-MS analysis revealed 13 bioactive compounds. Animals did not show any signs of toxicity and no death was recorded after administering upto 5g/kg of EPESA to rats. Oral administration of ESEPA resulted in a significant decrease (p<0.05) in the level of blood glucose, packed cell volume, haemogloblin, urea, creatine, aspartate transaminase, alanine transamine, total cholesterol, triacylglycerol, low density lipoprotein when compared with negative control groups. However, plasma levels of albumin, globulin and high density lipoprotein significantly increased (p<0.05) when treated groups are compared with the control. This study showed ESEPA is non-toxic but contains bioactive phytochemical with pharmacological activities such as antidiabetic, antilipidemic, hepatoprotective.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR